1-(4-DIMETHYLAMINOBENZAL)-INDENE (DABI, Fig. 1) was examined for tumour inhibitory activity against subcutaneous transplants of the Walker carcinosarcoma 256 at the request of Professor C. T. Bahner ...
Accurate classification of metastatic brain tumors using a novel microRNA-based test. Background: LTX-315 (Oncopore) is a chemically designed cationic nonapeptide derived from a natural host defensive ...
Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved atezolizumab and hyaluronidase-tqjs for subcutaneous injection. The agent (Tecentriq Hybreza, ...
A pilot study of docetaxel and carboplatin for treatment of patients with mCRPC containing biallelic inactivation of genes in the BRCA1/2 pathway. This is an ASCO Meeting Abstract from the 2020 ...
IV therapy delivers cancer medicine directly into a vein and often requires a longer infusion visit at a clinic or hospital. Subcutaneous therapy is an injection given under the skin and usually takes ...
OPDIVO is a prescription medicine used in combination with YERVOY as a first treatment to treat adults with cancer of the ...
Subcutaneous injections typically cause minimal pain since they involve small, short needles that do not penetrate deeply into the tissue. People may be able to reduce the pain of injections by ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved a subcutaneous induction regimen of guselkumab for the treatment of adults with moderately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results